Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Top Cited Papers
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cardiovascular Diabetology
- Vol. 13 (1), 65
- https://doi.org/10.1186/1475-2840-13-65
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trialsExpert Opinion on Pharmacotherapy, 2014
- SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitusJournal of Pharmacy and Pharmacology, 2012
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and MiceJournal of Pharmacology and Experimental Therapeutics, 2012
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on MetforminJournal of Clinical Endocrinology & Metabolism, 2012
- Glucagon-like peptide-1 analogues for type 2 diabetesBMJ, 2011
- SGLT2 inhibition — a novel strategy for diabetes treatmentNature Reviews Drug Discovery, 2010
- A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduriaKidney International, 2005
- Renal glucosuria due to SGLT2 mutationsMolecular Genetics and Metabolism, 2004
- Renal Na+-glucose cotransportersAmerican Journal of Physiology-Renal Physiology, 2001